Literature DB >> 17040259

Preliminary testing for normality: some statistical aspects of a common concept.

V Schoder1, A Himmelmann, K P Wilhelm.   

Abstract

BACKGROUND: Statistical methodology has become an increasingly important topic in dermatological research. Adequacy of the statistical procedure depends among others on distributional assumptions. In dermatological articles, the choice between parametric and nonparametric methods is often based on preliminary goodness-of-fit tests. AIM: For the special case of the assumption of normally distributed data, the Kolmogorov-Smirnov test is the most popular choice. We investigated the performance of this test on four types of non-normal data, representing the majority of real data in dermatological research.
METHODS: Simulations were run to assess the performance of the Kolmogorov-Smirnov test, depending on sample size and severity of violations of normality.
RESULTS: The Kolmogorov-Smirnov test performs badly on data with single outliers, 10% outliers and skewed data at sample sizes < 100, whereas normality is rejected to an acceptable degree for Likert-type data.
CONCLUSION: Preliminary testing for normality is not recommended for small-to-moderate sample sizes.

Mesh:

Year:  2006        PMID: 17040259     DOI: 10.1111/j.1365-2230.2006.02206.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

1.  To test or not to test: Preliminary assessment of normality when comparing two independent samples.

Authors:  Justine Rochon; Matthias Gondan; Meinhard Kieser
Journal:  BMC Med Res Methodol       Date:  2012-06-19       Impact factor: 4.615

2.  Are assumptions of well-known statistical techniques checked, and why (not)?

Authors:  Rink Hoekstra; Henk A L Kiers; Addie Johnson
Journal:  Front Psychol       Date:  2012-05-14

3.  A comparison between 2D and 3D methods of quantifying facial morphology.

Authors:  I Y Anas; B O Bamgbose; Saleh Nuhu
Journal:  Heliyon       Date:  2019-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.